Sep 18, 2020

MP Biomedicals facility in India is awarded both ISO 9001:2015 and WHO GMP certification

MP Biomedicals proudly announces the recent award of ISO 9001:2015 and WHO GMP certifications for manufacturing facility located in Navi Mumbai, in Maharashtra state of India.
Clients are assured global quality products with high consistency to support their manufacturing and research needs in Pharmaceutical and Diagnostic industries. Supported by qualified team of QA and QC professionals, MP Biomedicals meets highly stringent requirements with complete documentation and traceability.

Read more >

Aug 25, 2020

MP Biomedicals develops two new high-performance DNA extraction kits to advance both environmental and gut microbiome research

MP Biomedicals announced the launch of two new high-performance DNA extraction kits – SPINeasy™ DNA Kit for Soil and MagBeads FastDNA™ Kit for Feces for Feces – to advance your microbiome research.
Microbiome research has wide applications in agriculture, biofuel, ecology, environment remediation and healthcare. The characterization of soil and gut microbiome requires the extraction of genetic materials, but it is not an easy process as both sources have complex content which can hinder scientists from getting sufficient yield of DNA or DNA of high purity that can be used directly for downstream application.

Read more >

Jul 27, 2020

MP Biomedicals and A*Star Singapore Co-develop Rapid Antibody Point-of-Care Test Kit for SARS-CoV-2

ASSURE® SARS-CoV-2 IgG/IgM Rapid Test kit detects antibodies produced by the human immune system in response to exposure to COVID-19.

Read more >

Jun 05, 2020

FastPrep-24™ Classic used in COVID-19 Vaccine Development

MP Biomedicals FastPrep® Instruments help expedite COVID-19 current vaccine research with INOVIO Pharmaceuticals, University of Oxford and CSIRO in Australia.

MP Biomedicals is proud to see the FastPrep-24 Classic has been instrumental in SARS-CoV-2 therapeutic research. INOVIO Pharmaceuticals, together with University of Oxford and researchers at Commonwealth Scientific and Industrial Research Organization (CSIRO) in Australia, were featured on 9 News Australia showcasing their COVID-19 vaccine development.

Read more >

Mar 03, 2020

MP Biomedicals Announces Launch of SARS-CoV-2 Products

MP Biomedicals, a division of Valiant Co., Ltd., is stepping in to support scientists worldwide in understanding SARS-CoV-2 and discovering solutions to combat COVID-19 by launching several new monoclonal antibodies and recombinant antigens.

Read more >

Mar 06, 2019

Article in Genetic Engineering & Biotechnology, “High-Performance Density Gradient Media for Purification of Leukocytes from Blood”.

MP Bio describes formulations that isolate mononuclear and polymorphonuclear leukocytes with high yield and viability using Lymphocyte Separation Medium (LSM™), LymphoSep™, and Mono-Poly™ Resolving Medium.

Read more >

Jan 23, 2018

MP Biomedicals Announces New Dedicated Clean Rooms for Animal and Non-Animal Products

MP Biomedicals Announces New Dedicated Clean Rooms for Animal and Non-Animal Products

MP Biomedicals, LLC announces the installation of dedicated cleanrooms for animal origin (AO) and non-animal origin (NAO) products in their Solon, Ohio, USA facility. The addition of the ISO Class 6 clean rooms continues an ongoing initiative to meet the stringent quality control and regulatory compliance standards vital for biopharmaceutical and bioprocessing applications.

Read more >

Aug 23, 2017

MP Biomedicals Are Approved to Export Bovine Blood Products to China

MP Biomedicals has been approved for exports of bovine blood proteins into China. This approval, granted last month to 16 companies by the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China (AQSIQ) allows MP Biomedicals to export its entire range of bovine blood proteins into China. These products are used in the Life Science market for the manufacture of therapeutic monoclonal antibodies, vaccines, infectious disease media, diagnostic kits, cell culture media and other research purposes.

Read more >

Aug 16, 2017

MP Biomedicals, LLC Agrees to Sell Rapid Diagnostics Division

MP Biomedicals LLC, a leading provider of life science reagents, fine chemicals and diagnostic products for over 50 years, has agreed to sell the assets of their Rapid Diagnostics division to LumiQuick Diagnostics Inc., a manufacturer of high quality point of care tests and other immunoassay kits.

Read more >

Mar 18, 2016

Aquisition of MP Biomedicals by Valiant Co. Ltd

We are pleased to announce MP Biomedicals is now part of the Valiant Family, the acquisition of 100% membership interest of MP Biomedicals was completed on March 18. Valiant is ideally suitable to support MP's business with experienced R & D team, rich manufacturing capacity and abundant funding.

Read more >